- Filed
- Nov 27, 2024 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Nov 27, 2024 | 38.01M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 38.01M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 33.01M sh |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$171.61K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$231.72K |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $23 |
| Stockholders Equity restated | Q1 2024 · Mar 31, 2024 | −$1.53M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | −$1.66M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | −$3.42M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | −$3.24M |
| Current Liabilities restated | Q1 2024 · Mar 31, 2024 | $2.92M |
| Current Liabilities restated | Q1 2024 · Dec 31, 2023 | $2.45M |
| Total Liabilities restated | Q1 2024 · Mar 31, 2024 | $3.78M |
| Total Liabilities restated | Q1 2024 · Dec 31, 2023 | $4.42M |
| Current Assets restated | Q1 2024 · Mar 31, 2024 | $897.32K |
| Current Assets restated | Q1 2024 · Dec 31, 2023 | $300K |
| Total Assets restated | Q1 2024 · Mar 31, 2024 | $2.25M |
| Total Assets restated | Q1 2024 · Dec 31, 2023 | $2.76M |
| Eps Diluted restated | Q1 2024 · Mar 31, 2024 | $0.00 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$0.01 |
| Eps Basic restated | Q1 2024 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$0.01 |
| Sga Expense restated | Q1 2024 · Mar 31, 2024 | $151.83K |
| Sga Expense restated | Q1 2024 · Mar 31, 2023 | $24.31K |
| Net Income restated | Q1 2024 · Mar 31, 2024 | $133.94K |
| Net Income | Q1 2024 · Mar 31, 2023 | −$178.84K |
| Operating Income restated | Q1 2024 · Mar 31, 2024 | −$151.83K |
| Operating Income restated | Q1 2024 · Mar 31, 2023 | −$24.31K |